ALT (U/L), [median (IQR)] |
362 (201–528) |
52–3890 |
405 (211–648) |
52–3890 |
AST (U/L), [median (IQR)] |
171 (102–308) |
33–5990 |
201 (125–371) |
47–7525 |
Alkaline phosphatase (U/L), [median IQR (SD)] |
288 (210–380) |
123–1005 |
361 (252–551) |
144–1472 |
Total bilirubin (mg/dL), [median (IQR)] |
6 (4–9) |
0.5–26 |
13 (7–23) |
0.5–45 |
INR [median (IQR)] |
0.9 (0.9–1.1) |
0.8–4 |
1.1 (1.1–1.2) |
0.8–9 |
R value at onset [median (IQR)] |
2.7 (1.7–5) |
0.5–44 |
|
|
R value <2 n (%) |
37 (33) |
|
|
|
R value >2 and <5 n (%) |
48 (42) |
|
|
|
R value >5 n (%) |
29 (25) |
|
|
|
Positive HCV RNA n (%) |
2 (3 %) |
|
|
|
Positive ANA n (%) |
20 (18 %) |
|
|
|
Positive ASMA n (%) |
16 (15 %) |
|
|
|
Serum IgG (mg/dL) [median (IQR)] |
995 (793–1166) |
478–2840 |
|
|
Absolute eosinophil count (/uL) [median (IQR)] |
228 (99–357) |
0–1253 |
|
|